130 related articles for article (PubMed ID: 21664656)
21. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
[TBL] [Abstract][Full Text] [Related]
22. Expression of Yes-associated protein in cervical squamous epithelium lesions.
Xiao H; Wu L; Zheng H; Li N; Wan H; Liang G; Zhao Y; Liang J
Int J Gynecol Cancer; 2014 Nov; 24(9):1575-82. PubMed ID: 25304677
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical LRIG3 expression in cervical intraepithelial neoplasia and invasive squamous cell cervical cancer: association with expression of tumor markers, hormones, high-risk HPV-infection, smoking and patient outcome.
Lindström AK; Hellberg D
Eur J Histochem; 2014 Apr; 58(2):2227. PubMed ID: 24998916
[TBL] [Abstract][Full Text] [Related]
24. Risk Categorization with Different Grades of Cervical Pre-Neoplastic Lesions - High Risk HPV Associations and Expression of p53 and RARβ.
Ghosh D; Roy AK; Murmu N; Mandal S; Roy A
Asian Pac J Cancer Prev; 2019 Feb; 20(2):549-555. PubMed ID: 30803219
[TBL] [Abstract][Full Text] [Related]
25. Laminin-5 gamma 2 chain expression in cervical intraepithelial neoplasia and invasive cervical carcinoma.
Noel JC; Fernandez-Aguilar S; Fayt I; Buxant F; Ansion MH; Simon P; Anaf V
Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1119-23. PubMed ID: 16232183
[TBL] [Abstract][Full Text] [Related]
26. Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix.
Chen G; He C; Li L; Lin A; Zheng X; He E; Skog S
BMC Cancer; 2013 May; 13():249. PubMed ID: 23693054
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of DNA mismatch repair (MMR) system proteins (hMLH1, hMSH2) in cervical preinvasive and invasive lesions.
Ciavattini A; Piccioni M; Tranquilli AL; Filosa A; Pieramici T; Goteri G
Pathol Res Pract; 2005; 201(1):21-5. PubMed ID: 15807307
[TBL] [Abstract][Full Text] [Related]
28. nm23-H1 protein immunoreactivity in intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Lee CS; Gad J
Pathol Int; 1998 Oct; 48(10):806-11. PubMed ID: 9788265
[TBL] [Abstract][Full Text] [Related]
29. Role and significance of HER-2/neu as a biomarker in the premalignant and malignant lesions of uterine cervix.
Varshney S; Maheshwari V; Aijaz M; Alam K
Ann Diagn Pathol; 2020 Apr; 45():151443. PubMed ID: 31923745
[TBL] [Abstract][Full Text] [Related]
30. The expression of epithelial specific antigen in cervical intraepithelial neoplasia and adenocarcinoma.
Markaki S; Lazaris D; Papaspirou I; Paulou V
Eur J Gynaecol Oncol; 2004; 25(1):101-3. PubMed ID: 15053074
[TBL] [Abstract][Full Text] [Related]
31. [Expressions of bFGF and PTEN in cervical carcinoma and their clinical significance].
Luo CF; Hong HL; Lu YL; Wang H; Liu MQ
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):533-8. PubMed ID: 21029699
[TBL] [Abstract][Full Text] [Related]
32. p53 protein and tumorigenesis in the uterine cervix.
Lakshmi S; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Gen Diagn Pathol; 1997 Jun; 142(5-6):281-7. PubMed ID: 9228250
[TBL] [Abstract][Full Text] [Related]
33. Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.
Connolly DC; Greenspan DL; Wu R; Ren X; Dunn RL; Shah KV; Jones RW; Bosch FX; Muñoz N; Cho KR
Clin Cancer Res; 2000 Sep; 6(9):3505-10. PubMed ID: 10999736
[TBL] [Abstract][Full Text] [Related]
34. A functional network of the tumor suppressors APC, hDlg, and PTEN, that relies on recognition of specific PDZ-domains.
Sotelo NS; Valiente M; Gil A; Pulido R
J Cell Biochem; 2012 Aug; 113(8):2661-70. PubMed ID: 22434720
[TBL] [Abstract][Full Text] [Related]
35. p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer.
Amortegui AJ; Meyer MP; Elborne VL; Amin RM
Mod Pathol; 1995 Dec; 8(9):907-12. PubMed ID: 8751330
[TBL] [Abstract][Full Text] [Related]
36. Expression and clinical implications of enhancer of Zeste homolog 2 and p53 protein in squamous cell carcinoma and precancerous lesions in the cervix.
Zhang HM; Chen SQ; Yao SZ
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323178
[TBL] [Abstract][Full Text] [Related]
37. The two faces of cervical adenocarcinoma in situ.
Smedts F; Ramaekers FC; Hopman AH
Int J Gynecol Pathol; 2010 Jul; 29(4):378-85. PubMed ID: 20567153
[TBL] [Abstract][Full Text] [Related]
38. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer.
Wang JL; Zheng BY; Li XD; Angström T; Lindström MS; Wallin KL
Clin Cancer Res; 2004 Apr; 10(7):2407-14. PubMed ID: 15073118
[TBL] [Abstract][Full Text] [Related]
39. Aberrant p53 protein expression in cervical intra-epithelial neoplasia.
Pöllänen R; Soini Y; Vähäkangas K; Pääkkö P; Lehto VP
Histopathology; 1993 Nov; 23(5):471-4. PubMed ID: 8314222
[TBL] [Abstract][Full Text] [Related]
40. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
